Cargando…
Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma.
Very rapid progression of disease with a median survival of 6-9 months is a common feature of metastatic cutaneous malignant melanoma. Nevertheless, substantial variability of survival suggests that metastatic cutaneous malignant melanoma can be divided into several biological subgroups. Pretreatmen...
Autores principales: | Franzke, A., Probst-Kepper, M., Buer, J., Duensing, S., Hoffmann, R., Wittke, F., Volkenandt, M., Ganser, A., Atzpodien, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062938/ https://www.ncbi.nlm.nih.gov/pubmed/9662248 |
Ejemplares similares
-
Elevated serum levels of S100 and survival in metastatic malignant melanoma.
por: Buer, J., et al.
Publicado: (1997) -
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
por: Hoffmann, R, et al.
Publicado: (1999) -
Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a.
por: Hoffmann, R., et al.
Publicado: (1998) -
Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma
por: Wittke, F, et al.
Publicado: (1999) -
Identification of novel regulators in T-cell differentiation of aplastic anemia patients
por: Franzke, Anke, et al.
Publicado: (2006)